Literature DB >> 30098378

Early behavioral and metabolomic change after mild to moderate traumatic brain injury in the developing brain.

Jyothsna Chitturi1, Ying Li2, Vijayalakshmi Santhakumar3, Sridhar S Kannurpatti4.   

Abstract

Pathophysiology of developmental traumatic brain injury (TBI) is unique due to intrinsic differences in the developing brain. Energy metabolic studies of the brain during early development (P13 to P30) have indicated acute oxidative energy metabolic decreases below 24 h after TBI, which generally recovered by 48 h. However, marked neurodegeneration and altered neural functional connectivity have been observed at later stages into adolescence. As secondary neurodegeneration is most prominent during the first week after TBI in the rat model, we hypothesized that the subacute TBI-metabolome may contain predictive markers of neurodegeneration. Sham and TBI metabolomes were examined at 72 h after a mild to moderate intensity TBI in male Sprague-Dawley rats aged P31. Sensorimotor behavior was assessed at 24, 48 and 72 h after injury, followed by 72-hour postmortem brain removal for metabolomics using Liquid Chromatography/Mass Spectrometry (LC-MS) measurement. Broad TBI-induced metabolomic shifts occurred with relatively higher intensity in the injury-lateralized (ipsilateral) hemisphere. Intensity of metabolomic perturbation correlated with the extent of sensorimotor behavioral deficit. N-acetyl-aspartate (NAA) levels at 72 h after TBI, predicted the extent of neurodegeneration assessed histochemically 7-days post TBI. Results from the multivariate untargeted approach clearly distinguished metabolomic shifts induced by TBI. Several pathways including amino acid, fatty acid and energy metabolism continued to be affected at 72 h after TBI, whose collective effects may determine the overall pathological response after TBI in early development including neurodegeneration.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fluid percussion; Glycolysis; Liquid chromatography; Mass spectrometry; Metabolomics; Pediatric; Sensorimotor behavior; TCA cycle; Traumatic brain injury

Mesh:

Substances:

Year:  2018        PMID: 30098378      PMCID: PMC6257993          DOI: 10.1016/j.neuint.2018.08.003

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  47 in total

1.  Acute and late changes in N-acetyl-aspartate following diffuse axonal injury in rats: an MRI spectroscopy and microdialysis study.

Authors:  B Alessandri; R al-Samsam; F Corwin; P Fatouros; H F Young; R M Bullock
Journal:  Neurol Res       Date:  2000-10       Impact factor: 2.448

Review 2.  The potential role of mitochondria in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Lucian Soane; Zachary T Siegel; Gary Fiskum
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

Review 3.  Traumatic brain injury: can the consequences be stopped?

Authors:  Eugene Park; Joshua D Bell; Andrew J Baker
Journal:  CMAJ       Date:  2008-04-22       Impact factor: 8.262

Review 4.  Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders.

Authors:  Dénes Zádori; Péter Klivényi; Levente Szalárdy; Ferenc Fülöp; József Toldi; László Vécsei
Journal:  J Neurol Sci       Date:  2012-06-27       Impact factor: 3.181

5.  Decrease in tonic inhibition contributes to increase in dentate semilunar granule cell excitability after brain injury.

Authors:  Akshay Gupta; Fatima S Elgammal; Archana Proddutur; Samik Shah; Vijayalakshmi Santhakumar
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

6.  Impaired cerebral mitochondrial function after traumatic brain injury in humans.

Authors:  B H Verweij; J P Muizelaar; F C Vinas; P L Peterson; Y Xiong; C P Lee
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

7.  N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury.

Authors:  C Demougeot; P Garnier; C Mossiat; N Bertrand; M Giroud; A Beley; C Marie
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

8.  Methylene blue is neuroprotective against mild traumatic brain injury.

Authors:  Lora Talley Watts; Justin Alexander Long; Jonathan Chemello; Samantha Van Koughnet; Angelica Fernandez; Shiliang Huang; Qiang Shen; Timothy Q Duong
Journal:  J Neurotrauma       Date:  2014-04-08       Impact factor: 5.269

9.  MetaboAnalyst 3.0--making metabolomics more meaningful.

Authors:  Jianguo Xia; Igor V Sinelnikov; Beomsoo Han; David S Wishart
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

10.  Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury.

Authors:  Sunil A Sheth; Anthony T Iavarone; David S Liebeskind; Seok Joon Won; Raymond A Swanson
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

View more
  12 in total

1.  Beneficial Effects of Kaempferol after Developmental Traumatic Brain Injury Is through Protection of Mitochondrial Function, Oxidative Metabolism, and Neural Viability.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

2.  Supraspinal Sensorimotor and Pain-Related Reorganization after a Hemicontusion Rat Cervical Spinal Cord Injury.

Authors:  Basavaraju G Sanganahalli; Jyothsna Chitturi; Peter Herman; Stella Elkabes; Robert Heary; Fahmeed Hyder; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2021-12       Impact factor: 5.269

3.  Association Between Magnetic Resonance Imaging-Based Spinal Morphometry and Sensorimotor Behavior in a Hemicontusion Model of Incomplete Cervical Spinal Cord Injury in Rats.

Authors:  Jyothsna Chitturi; Basavaraju G Sanganahalli; Peter Herman; Fahmeed Hyder; Li Ni; Stella Elkabes; Robert Heary; Sridhar S Kannurpatti
Journal:  Brain Connect       Date:  2020-10-29

4.  Kaempferol Treatment after Traumatic Brain Injury during Early Development Mitigates Brain Parenchymal Microstructure and Neural Functional Connectivity Deterioration at Adolescence.

Authors:  Maxime Parent; Jyothsna Chitturi; Vijayalakshmi Santhakumar; Fahmeed Hyder; Basavaraju G Sanganahalli; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2020-02-06       Impact factor: 5.269

5.  Traumatic brain injury metabolome and mitochondrial impact after early stage Ru360 treatment.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  Mitochondrion       Date:  2021-01-21       Impact factor: 4.160

Review 6.  Impact of pediatric traumatic brain injury on hippocampal neurogenesis.

Authors:  Mariam Rizk; Justin Vu; Zhi Zhang
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

7.  Consolidated Biochemical Profile of Subacute Stage Traumatic Brain Injury in Early Development.

Authors:  Jyothsna Chitturi; Ying Li; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  Front Neurosci       Date:  2019-05-03       Impact factor: 4.677

8.  Organophosphorus flame retardants are developmental neurotoxicants in a rat primary brainsphere in vitro model.

Authors:  Helena T Hogberg; Rita de Cássia da Silveira E Sá; Andre Kleensang; Mounir Bouhifd; Ozge Cemiloglu Ulker; Lena Smirnova; Mamta Behl; Alexandra Maertens; Liang Zhao; Thomas Hartung
Journal:  Arch Toxicol       Date:  2020-10-19       Impact factor: 5.153

9.  Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness.

Authors:  Jie Yu; Fanxia Meng; Fangping He; Fei Chen; Wangxiao Bao; Yamei Yu; Jintao Zhou; Jian Gao; Jingqi Li; Yao Yao; Woo-Ping Ge; Benyan Luo
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

10.  VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury.

Authors:  Zian Xia; Wenbin Liu; Fei Zheng; Wei Huang; Zhihua Xing; Weijun Peng; Tao Tang; Jiekun Luo; Lunzhao Yi; Yang Wang
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.